One-year follow-up of a nationwide cohort of patients with inflammatory arthritis, who switched from originator to biosimilar etanercept, focusing on patients who switched back to originator: an observational danbio study

B. Glintborg; I.J. Sørensen; E. Omerovic; F. Mehnert; N. Manilo; K. Danebod; D.V. Jensen; H. Nordin; A.G. Loft; O. Hendricks; S. Chrysidis; B.L. Andersen; J.L. Raun; H. Lindegaard; J. Espesen; S.H. Jakobsen; I.M.J. Hansen; E.B. Dalsgaard; D.D. Pedersen; S. Kristensen; A. Linauskas; L.S. Andersen; J. Grydehøj; N.S. Krogh; M.L. Hetland

doi:10.1136/annrheumdis-2018-eular.2296

One-year follow-up of a nationwide cohort of patients with inflammatory arthritis, who switched from originator to biosimilar etanercept, focusing on patients who switched back to originator: an observational danbio study

B. Glintborg, I.J. Sørensen, E. Omerovic, F. Mehnert, N. Manilo, K. Danebod, D.V. Jensen, H. Nordin, A.G. Loft, O. Hendricks, S. Chrysidis, B.L. Andersen, J.L. Raun, H. Lindegaard, J. Espesen, S.H. Jakobsen, I.M.J. Hansen, E.B. Dalsgaard, D.D. Pedersen, S. KristensenA. Linauskas, L.S. Andersen, J. Grydehøj, N.S. Krogh, M.L. Hetland

Institut for Klinisk Medicin

Originalsprog	Engelsk
Artikelnummer	FRI0103
Tidsskrift	Annals of the Rheumatic Diseases
Vol/bind	77
Udgave nummer	Suppl 2
Antal sider	2
ISSN	0003-4967
DOI	https://doi.org/10.1136/annrheumdis-2018-eular.2296
Status	Udgivet - 2018

Adgang til dokumentet

10.1136/annrheumdis-2018-eular.2296

595.2.full.pdfForlagets udgivne version, 402 KB

Citationsformater

Glintborg, B., Sørensen, I. J., Omerovic, E., Mehnert, F., Manilo, N., Danebod, K., Jensen, D. V., Nordin, H., Loft, A. G., Hendricks, O., Chrysidis, S., Andersen, B. L., Raun, J. L., Lindegaard, H., Espesen, J., Jakobsen, S. H., Hansen, I. M. J., Dalsgaard, E. B., Pedersen, D. D., ... Hetland, M. L. (2018). One-year follow-up of a nationwide cohort of patients with inflammatory arthritis, who switched from originator to biosimilar etanercept, focusing on patients who switched back to originator: an observational danbio study. Annals of the Rheumatic Diseases, 77(Suppl 2), [FRI0103]. https://doi.org/10.1136/annrheumdis-2018-eular.2296

One-year follow-up of a nationwide cohort of patients with inflammatory arthritis, who switched from originator to biosimilar etanercept, focusing on patients who switched back to originator : an observational danbio study. / Glintborg, B.; Sørensen, I.J.; Omerovic, E. et al.

I: Annals of the Rheumatic Diseases, Bind 77, Nr. Suppl 2, FRI0103, 2018.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Glintborg, B, Sørensen, IJ, Omerovic, E, Mehnert, F, Manilo, N, Danebod, K, Jensen, DV, Nordin, H, Loft, AG, Hendricks, O, Chrysidis, S, Andersen, BL, Raun, JL, Lindegaard, H, Espesen, J, Jakobsen, SH, Hansen, IMJ, Dalsgaard, EB, Pedersen, DD, Kristensen, S, Linauskas, A, Andersen, LS, Grydehøj, J, Krogh, NS & Hetland, ML 2018, ' One-year follow-up of a nationwide cohort of patients with inflammatory arthritis, who switched from originator to biosimilar etanercept, focusing on patients who switched back to originator: an observational danbio study', Annals of the Rheumatic Diseases, bind 77, nr. Suppl 2, FRI0103. https://doi.org/10.1136/annrheumdis-2018-eular.2296

Glintborg B, Sørensen IJ, Omerovic E, Mehnert F, Manilo N, Danebod K et al. One-year follow-up of a nationwide cohort of patients with inflammatory arthritis, who switched from originator to biosimilar etanercept, focusing on patients who switched back to originator: an observational danbio study. Annals of the Rheumatic Diseases. 2018;77(Suppl 2):FRI0103. doi: 10.1136/annrheumdis-2018-eular.2296

@article{9f88962c88874020a393a0f88ebccfe7,

title = " One-year follow-up of a nationwide cohort of patients with inflammatory arthritis, who switched from originator to biosimilar etanercept, focusing on patients who switched back to originator: an observational danbio study",

author = "B. Glintborg and I.J. S{\o}rensen and E. Omerovic and F. Mehnert and N. Manilo and K. Danebod and D.V. Jensen and H. Nordin and A.G. Loft and O. Hendricks and S. Chrysidis and B.L. Andersen and J.L. Raun and H. Lindegaard and J. Espesen and S.H. Jakobsen and I.M.J. Hansen and E.B. Dalsgaard and D.D. Pedersen and S. Kristensen and A. Linauskas and L.S. Andersen and J. Grydeh{\o}j and N.S. Krogh and M.L. Hetland",

year = "2018",

doi = "10.1136/annrheumdis-2018-eular.2296",

language = "English",

volume = "77",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "B M J Group",

number = "Suppl 2",

}

TY - ABST

T1 - One-year follow-up of a nationwide cohort of patients with inflammatory arthritis, who switched from originator to biosimilar etanercept, focusing on patients who switched back to originator

T2 - an observational danbio study

AU - Glintborg, B.

AU - Sørensen, I.J.

AU - Omerovic, E.

AU - Mehnert, F.

AU - Manilo, N.

AU - Danebod, K.

AU - Jensen, D.V.

AU - Nordin, H.

AU - Loft, A.G.

AU - Hendricks, O.

AU - Chrysidis, S.

AU - Andersen, B.L.

AU - Raun, J.L.

AU - Lindegaard, H.

AU - Espesen, J.

AU - Jakobsen, S.H.

AU - Hansen, I.M.J.

AU - Dalsgaard, E.B.

AU - Pedersen, D.D.

AU - Kristensen, S.

AU - Linauskas, A.

AU - Andersen, L.S.

AU - Grydehøj, J.

AU - Krogh, N.S.

AU - Hetland, M.L.

PY - 2018

Y1 - 2018

U2 - 10.1136/annrheumdis-2018-eular.2296

DO - 10.1136/annrheumdis-2018-eular.2296

M3 - Conference abstract in journal

SN - 0003-4967

VL - 77

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - Suppl 2

M1 - FRI0103

ER -